基于乳腺X线表现评估筛查乳腺超声检出的非肿块病变
这项回顾性多中心研究纳入2012年1月至2019年12月接受筛查超声的无症状女性,共993个非肿块病变(993例患者),其中良性914个(92.0%)、恶性79个(8.0%)。多变量分析显示,超声上伴随钙化、后方声影、段性分布、混合回声及较大尺寸与恶性相关;乳腺X线阴性者的恶性率(2.8% vs 28.8%)及超声特征阳性预测值(0.7%-10.4% vs 24%-55%)均低于乳腺X线阳性者。
要点
- 筛查超声检出的非肿块病变中,伴随钙化、后方声影、段性分布、混合回声为可疑恶性征象。
- 乳腺X线阴性时非肿块病变恶性率2.8%,低于乳腺X线阳性的28.8%。
- 乳腺X线阴性时超声征象阳性预测值0.7%-10.4%,低于乳腺X线阳性的24%-55%。
核心结论
- 伴随钙化、后方声影、段性分布和混合回声的非肿块病变可视为筛查超声中可疑恶性征象。
- 由于恶性率和阳性预测值随乳腺X线异常不同而变化,必须结合乳腺X线表现综合评估。
研究设计与样本
- 回顾性多中心研究,纳入2012年1月至2019年12月接受筛查超声的无症状女性。
- 纳入条件为超声检出非肿块病变、同期接受筛查乳腺X线检查且有最终诊断记录。
- 共993个非肿块病变(993例患者),平均年龄50岁±9(标准差)。
- 采用逻辑回归分析识别与恶性相关的因素,并按乳腺X线表现计算各超声特征的诊断效能。
- 进行阅片者研究评估超声特征的阅片者间一致性。
关键影像表现/征象
- 恶性非肿块病变平均大小大于良性病变(2.6 cm±1.1 vs 1.9 cm±0.8;P < .001)。
- 超声上伴随钙化、后方声影、段性分布、混合回声及尺寸与恶性相关。
诊断标准与关键数值
- 多变量分析中,伴随钙化与恶性相关(OR 21.6 [95%CI: 8.0, 58.2];P < .001)。
- 后方声影与恶性相关(OR 6.9 [95%CI: 2.6, 18.4];P < .001)。
- 段性分布与恶性相关(OR 6.2 [95%CI: 2.7, 14.4];P < .001)。
- 混合回声与恶性相关(OR 5.0 [95%CI: 1.8, 14.0];P < .001);尺寸与恶性相关(OR 1.5 [95%CI: 1.1, 2.1];P = .01)。
- 伴随钙化、后方声影、段性分布、混合回声的阳性预测值分别为44%、22%、22.9%、16.6%。
临床应用与阅片要点
- 乳腺X线阴性者非肿块病变恶性率为2.8%,低于乳腺X线阳性者的28.8%。
- 乳腺X线阴性者超声特征的阳性预测值为0.7%-10.4%,低于乳腺X线阳性者的24%-55%。
- 超声特征阅片者间一致性为良好至优秀(Fleiss κ 95%CI下限范围0.63-0.81)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Breast nonmass lesions (NMLs) are observed at screening and diagnostic US. However, knowledge is limited on imaging features of NMLs at screening US. Purpose To identify features of NMLs at screening US that are suspicious for malignancy based on mammographic findings. Materials and Methods This retrospective, multicenter study included asymptomatic women who underwent screening US between January 2012 and December 2019. Eligible women had NMLs at US, concurrent screening mammography, and record of a final diagnosis. Logistic regression analyses were used to identify factors associated with malignancy. The diagnostic performance of each sonographic feature according to mammographic findings was calculated. A reader study was performed to assess interreader agreement for sonographic features. Results Among 993 NMLs in 993 patients (mean age, 50 years ± 9 [SD]), 914 (92.0%) were benign and 79 (8.0%) were malignant. Mean size was larger for malignant NMLs than for benign NMLs (2.6 cm ± 1.1 vs 1.9 cm ± 0.8; P < .001). In multivariable analysis, associated calcifications (odds ratio [OR], 21.6 [95% CI: 8.0, 58.2]; P < .001), posterior shadowing (OR, 6.9 [95% CI: 2.6, 18.4]; P < .001), segmental distribution (OR, 6.2 [95% CI: 2.7, 14.4]; P < .001), mixed echogenicity (OR, 5.0 [95% CI: 1.8, 14.0]; P < .001), and size (OR, 1.5 [95% CI: 1.1, 2.1]; P = .01) at US were associated with malignancy. Associated calcifications, posterior shadowing, segmental distribution, and mixed echogenicity showed positive predictive values (PPVs) of 44%, 22%, 22.9%, and 16.6%, respectively. Having a negative mammogram was associated with a lower malignancy rate (2.8% vs 28.8%) and lower PPVs for sonographic features (0.7%-10.4% vs 24%-55%) than having a positive mammogram. Interreader agreement for sonographic features was good to excellent (Fleiss κ 95% CI lower bound range, 0.63-0.81). Conclusion Calcifications, posterior shadowing, segmental distribution, and mixed echogenicity associated with NMLs can be considered suspicious features for malignancy at screening US. As malignancy rates and PPVs differ according to mammographic abnormalities, combined assessment is mandatory. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Grimm in this issue.
引用
- Ha SM, Choi WJ, Han BK, et al. Assessment of Nonmass Lesions Detected with Screening Breast US Based on Mammographic Findings. Radiology. 2024. PMID: 39499173. doi:10.1148/radiol.240043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。